Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vera Therapeutics Inc VERA

Healthcare Biotechnology
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VERA)

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 7 days ago

Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer

GlobeNewswire 11 days ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 11, 2024

Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study

GlobeNewswire November 11, 2024

Vera Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire November 8, 2024

Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

GlobeNewswire October 29, 2024

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

GlobeNewswire October 28, 2024

Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

GlobeNewswire October 26, 2024
View More News ››

Opinion & Analysis (NDAQ:VERA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VERA)

Vera Therapeutics, Inc. (NASDAQ:VERA): A Late-Stage Biotech

http://beyondspx.com/2024/08/01/vera-therapeutics-inc-nasdaqvera-a-late-stage-biotech-poised-for-transformative-growth/
MikeTester - August 2, 2024

(VERA) Pivots Trading Plans and Risk Controls

BREAKING NEWS: $VERA (VERA) Pivots Trading Plans and Risk Controls2024-06-15 11:18:00 ET Stock Traders Daily has produced this trading...
whytestocks - June 15, 2024

Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rental

Breaking News: $VERA Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rentals And Other Big Stocks Moving Higher On Thursday...
whytestocks - January 25, 2024
View more Bullboard ››

Goldflare Exploration Inc

Goldflare Exploration Inc

Goldflare Exploration Inc. is a mineral exploration company. The Company specializes in gold exploration in the province of ...
View More »